Sign up to save your podcasts
Or
Share MoonLake Leaders On Its Fast-Track Vision And $500m Deal
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MoonLake Leaders On Its Fast-Track Vision And $500m Deal
MoonLake Immunotherapeutics is racing ahead in the biotech space with its innovative nanobody SLK and a transformative $500m non-dilutive financing deal. Its CEO and CFO discuss with In Vivo the company’s rapid clinical progress, financial strategy and ambitions to reshape inflammatory disease.
View all episodes
By Citeline
4.1
2828 ratings
MoonLake Immunotherapeutics is racing ahead in the biotech space with its innovative nanobody SLK and a transformative $500m non-dilutive financing deal. Its CEO and CFO discuss with In Vivo the company’s rapid clinical progress, financial strategy and ambitions to reshape inflammatory disease.
More shows like Citeline Podcasts
View all
Marketplace Tech
1,270 Listeners
WSJ Your Money Briefing
1,714 Listeners
WSJ What’s News
4,352 Listeners
Bloomberg Intelligence
410 Listeners
HBR IdeaCast
1,834 Listeners
How to Be Awesome at Your Job
1,032 Listeners
GZERO World with Ian Bremmer
782 Listeners
The Readout Loud
325 Listeners
Thoughts on the Market
1,294 Listeners
The Journal.
6,059 Listeners
The Next Big Idea
1,292 Listeners
BioCentury This Week
34 Listeners
Coaching Real Leaders
665 Listeners
Biotech Hangout
19 Listeners
HBR On Leadership
158 Listeners